Accordingly, TF derivatives, particularly tenofovir disoproxil (TDF, Figure 1), in combination with the other drugs cobicistat, elvitegravir, emtricitabine, and rilpivirine, have been extensively exploited as prodrugs of TF for the treatment of HIV-1 infections [11,13]. This evidence concerns the gene TF and HIV-1 infection.